rs606231142
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM4_SupportingPP5_Very_Strong
The NM_033629.6(TREX1):c.599_601dupATG(p.Asp200dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,614,030 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_033629.6 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TREX1 | NM_033629.6 | c.599_601dupATG | p.Asp200dup | disruptive_inframe_insertion | Exon 2 of 2 | ENST00000625293.3 | NP_338599.1 | |
ATRIP | NM_130384.3 | c.*1700_*1702dupATG | 3_prime_UTR_variant | Exon 13 of 13 | ENST00000320211.10 | NP_569055.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TREX1 | ENST00000625293.3 | c.599_601dupATG | p.Asp200dup | disruptive_inframe_insertion | Exon 2 of 2 | 6 | NM_033629.6 | ENSP00000486676.2 | ||
ATRIP | ENST00000320211.10 | c.*1700_*1702dupATG | 3_prime_UTR_variant | Exon 13 of 13 | 1 | NM_130384.3 | ENSP00000323099.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250998Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135718
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461792Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727200
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74366
ClinVar
Submissions by phenotype
Aicardi-Goutieres syndrome 1 Pathogenic:1Other:1
- -
- -
Systemic lupus erythematosus;C0024145:Chilblain lupus 1;C0796126:Aicardi-Goutieres syndrome 1;C1860518:Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations Pathogenic:1
- -
not provided Pathogenic:1
Published functional studies demonstrate that this variant is associated with reduced enzyme activity (de Silva et al., 2007; Orebaugh et al., 2011); In-frame insertion of 1 amino acid in a non-repeat region; This variant is associated with the following publications: (PMID: 17293595, 21937424, 26182405, 16845398, 20301648) -
Chilblain lupus 1;C0796126:Aicardi-Goutieres syndrome 1;C1860518:Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations Pathogenic:1
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this variant affects TREX1 function (PMID: 17293595, 21937424). This variant is present in population databases (rs755094515, gnomAD 0.007%). This variant, c.599_601dup, results in the insertion of 1 amino acid(s) of the TREX1 protein (p.Asp200dup), but otherwise preserves the integrity of the reading frame. ClinVar contains an entry for this variant (Variation ID: 4181). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. This variant has been observed in individual(s) with autosomal recessive Aicardi-Goutieres syndrome (PMID: 16845398). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as D201ins and 600_601insGAT. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at